Lifeboat Foundation

Philadelphia, PA, USA / Mexico City, Mexico — Bioquark, Inc., (www.bioquark.com) a life sciences company focused on the development of novel bioproducts for complex regeneration, disease reversion, and aging, and RegenerAge SAPI de CV, (www.regenerage.clinic/en/) a clinical company focused on translational therapeutic applications of a range of regenerative and rejuvenation healthcare interventions, have announced a collaboration to focus on novel combinatorial approaches in human disease and wellness. SGR-Especializada (http://www.sgr-especializada.com/), regulatory experts in the Latin American healthcare market, assisted in the relationship.

“We are very excited about this collaboration with RegenerAge SAPI de CV,” said Ira S. Pastor, CEO, Bioquark Inc. “The natural synergy of our cellular and biologic to applications of regenerative and rejuvenative medicine will make for novel and transformational opportunities in a range of degenerative disorders.”

As we close in on $7 trillion in total annual health care expenditures around the globe ($1 trillion spent on pharmaceutical products; $200 billion on new R&D), we are simultaneously witnessing a paradoxical rise in the prevalence of all chronic degenerative diseases responsible for human suffering and death.

Continue reading “Bioquark Inc. and RegenerAge SAPI de CV to Collaborate on Clinical Regenerative Healthcare” »

Apple’s new app to help you do deep breathing to improve your mind, intelligence, and over all health.

APPLE is set to launch a new app that aims to make you healthier through just a few minutes a day of deep breathing.

It is based on the growing field of research proving the biological benefits, including genetic changes, of mind-body medicine.

Continue reading “Now there’s an app to help you breathe” »

Interesting read to an old question.

New research explores what influences our intelligence and how we can give ourselves an upgrade.

By Sally Blundell In Health

Continue reading “How much sway do our genes really hold over our IQ?” »

Education and socioeconomic status have been linked with cancer outcomes, but a new study now links higher education with the development of certain types of cancer.

The large observational study, published in the Journal of Epidemiology and Community Health, reports that a high level of education is associated with an increased risk of brain tumors. The study is based on data from 4.3 million Swedish adults who were monitored between 1993 and 2010. Overall, 5,735 men and 7,101 women developed a brain tumor during the observation period.

Men with at least three years of university-level education had a 19% greater risk of developing gliomas than men with only a compulsory level of education (nine years). Women with the same level of education had a 23% increased risk of gliomas and a 16% increased risk of meningiomas. Marital status and amount of disposable income only slightly affected the risk among men but not among women. Single men had a lower risk of glioma but a higher risk of meningiomas. Occupation also influenced brain tumor risks among men and women: men in professional and management roles had a 20% increased risk of gliomas and a 50% increased risk of acoustic neuromas; women in these roles had a 26% increased risk of gliomas and a 14% increased risk of meningiomas.

Continue reading “Education Linked to Brain Tumor Risk” »

A new story with lots of transhumanism in it:

Zoltan Istvan is in the running for President of the United States. You may not have heard of him, but if elected, he hopes to put an end to death. All of it. (Yes, seriously).

There are people right now walking around with artificial hearts – something that many people believed would not happen for another decade (or even longer). There are quadriplegics no longer bound to a wheelchair, but walk with exoskeleton technology. There are hundreds of thousands of people with brain implants that help them with various ailments. In short, recent technological breakthroughs like these open up the possibility for humans to enhance themselves and their health—and perhaps to even become immortal (someday).

Continue reading “The U.S. Presidential Candidate Who Loves Science, Technology, And…Immortality?” »

Sure, chatbots are useful for service industries like hospitality and food delivery, but in health care? Some groups are testing the use of chatbots to retrieve medical information from within a messaging app. At first glance, that seems a bit impersonal, but a closer look reveals a wide range of use cases where bots could make your next visit to the hospital, doctor’s office, or pharmacy faster and more effective.

Let’s run this back a bit. If you’re not familiar with bots, here’s a brief explanation. Bots are software applications that run automated tasks or scripts that serve as shortcuts for completing a certain job, but they do it faster (a lot faster) and with verve. And in health care, we spend a lot of time spent generating and retrieving information.

By putting a trained army of bots inside an application — smartphone, desktop, whatever-top — health care workers can rapidly improve throughput by simply cutting out a bunch of steps. That’s something most care providers today would welcome, especially with millions of new people entering the system as a result of the Affordable Care Act and the aging of baby boomers. With the crush of increased data entry and new regulations, costs and rote work are skyrocketing.

Continue reading “How the most connected hospitals will use chatbots” »

Heart attack patients who were not expected to live are fit and healthy after scientists regenerated their hearts with stem cells in a ground-breaking trial which could help millions of people with heart failure.

The research is the first to show that scarring of heart muscle, associated with a heart attack can be reversed, a feat which doctors believed was impossible, and which could eventually end the need for transplants.

Scarring of the heart stops the organ pumping blood effectively and can lead to further attacks and sudden death.

Continue reading “Major breakthrough against heart failure after scientists use stem cells in ‘astonishing’ trial which could help millions” »

Dutch artist Daan Roosegaarde has come up with an innovative plan to tackle Beijing’s air pollution problem – and in doing so, turn a health hazard into a thing of beauty.

After a pilot in Rotterdam, the Smog Free Project is coming to China. The project consists of two parts. First, a 7m tall tower sucks up polluted air, and cleans it at a nano-level. Second, the carbon from smog particles is turned into diamonds. Yes, diamonds.

Continue reading “Why turning China’s smog into diamonds isn’t as crazy as it sounds” »

(Medical Xpress)—A team of researchers at Sichuan University’s West China Hospital has announced plans to begin a clinical trial where cells modified using the CRISPR gene editing technique will be used on human beings for the very first time. They plan to edit genes in such a way as to turn off a gene that encodes for a protein that has been shown by prior research to slow an immune response and by so doing treat patients with lung cancer.

The CRISPR gene editing technique has been in the news a lot of late as scientists creep ever closer to using it as a means to treat diseases or to change the very nature of biological beings. China has been a leader in promoting such research on human beings—they were the first to use the technique to on human embryos.

This new effort is seen as far less controversial—a team in the U.S. is planning a similar study as soon as they can get regulators to greenlight their project. The Chinese team plans to retrieve T cells from patients that have incurable lung cancer and then edit the genes in those cells. More specifically, they will be looking to disable a gene that encodes for a protein called PD-1—prior research has shown that it acts as a brake on an immune response to help prevent attacks on healthy cells. Once the cells have been edited and inspected very carefully to make sure there were no editing errors they will be allowed to multiply and then all of the cells will be injected back into the same patient’s bloodstream. It is hoped that the edited cells will cause the immune system to mount a more aggressive attack on tumor cells, killing them and curing the patient.

Continue reading “Chinese team to pioneer first human CRISPR trial” »